Kisai, Japan

Hiroyasu Sekine


Average Co-Inventor Count = 4.8

ph-index = 2

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1984

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Hiroyasu Sekine: Innovator in Pharmaceutical Chemistry

Introduction

Hiroyasu Sekine is a notable inventor based in Kisai, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative compounds. With a total of 2 patents, Sekine's work has garnered attention in the scientific community.

Latest Patents

Sekine's latest patents include the development of Guanidinocyclohexanecarboxylic acid derivatives. This compound features a complex formula where R1 represents various groups such as indanyl, indolyl, quinolyl, or chromonyl. The compound is synthesized by reacting 4-guanidinomethylcyclohexanecarboxylic acid with a suitable derivative. Another significant patent is for Amidinopiperidine derivatives, which are effective in inhibiting complement reactions, inflammation from allergic reactions, and platelet aggregation. This compound also has a detailed formula that includes various substituents and functional groups.

Career Highlights

Hiroyasu Sekine is currently associated with Nippon Chemiphar Co., Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in developing new therapeutic agents that address various medical conditions.

Collaborations

Sekine has collaborated with notable colleagues such as Mutsumi Muramatsu and Toshio Satoh. Their combined expertise has contributed to the advancement of their research and development efforts.

Conclusion

Hiroyasu Sekine's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor. His innovative compounds have the potential to make significant impacts in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…